https://www.marketscreener.com/quote/stock/DAEWOONG-PHARMACEUTICAL-C-6495262/news/Daewoong-Therapeutics-Gets-Mfds-Nod-for-Phase-1-Ind-for-the-World-s-First-Eyedrop-Treatment-for-Diab-44943487/?utm_source=telegram&utm_medium=social&utm_campaign=share